AbCellera Biologics Inc
ABCL
Market Cap$1.14B
Close$
$-3.16
179.6% downside
Current Fair Value
179.6% downsideOvervalued by 179.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.14 Billion |
|---|---|
| Enterprise Value | $455.42 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.51 |
| Beta | 1.33 |
| Outstanding Shares | 292,782,152 |
| Avg 30 Day Volume | 1,042,854 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -7.82 |
|---|---|
| PEG | -13.55 |
| Price to Sales | - |
| Price to Book Ratio | 1.32 |
| Enterprise Value to Revenue | 11.98 |
| Enterprise Value to EBIT | -1.92 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
ESG Score
No data